Viewing nowGlimepyridine 2 mg Tablets (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 201404010 · Approved 2014.08.28 · Insurance code 646203660
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It acts as an adjunct to dietary and exercise therapy and can be used alone. If blood sugar control is insufficient with monotherapy, it can be combined with other oral hypoglycemic agents or insulin. Particularly when control is difficult with sulfonylureas or monotherapy with metformin, it can be used in conjunction with metformin to assist in more effective blood sugar control. This medication plays a vital role in improving blood sugar management and is widely used in the treatment of type 2 diabetes.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medication is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medication There is no exact dose equivalence between this medication and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medication, it is recommended to follow the method described under Initial dose. That is, initiate treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medication should be taken into account. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. This medication is administered at a dose of 8 mg once daily with the first meal, and insulin is started at a low dose and increased at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medication is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia when this medication is administered in combination with metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Also, it should not be administered to those who are allergic to this medication, its components, or sulfonylureas. Patients with severe liver or kidney dysfunction should not use this medication as they have no experience with it and it is recommended to switch to insulin therapy. Pregnant or breastfeeding women should also refrain from taking this medication. In cases of severe infection, preoperative or postoperative conditions, or severe trauma, insulin therapy may be necessary. If gastrointestinal disorders such as diarrhea or vomiting occur, caution is advised as food absorption may be poor, increasing the risk of hypoglycemia. This medication contains lactose and should not be administered to patients with genetic metabolic disorders like galactose intolerance. There is a high risk of hypoglycemia in the early stages of treatment, thus elderly patients or those with irregular eating habits, and patients with decreased kidney or liver function should frequently check their blood sugar levels. If symptoms of hypoglycemia occur, immediate sugar intake is necessary, and if the symptoms are severe, consult medical personnel. When taken with other medications, interactions may influence blood sugar control, so it is essential to inform healthcare professionals. This medication contains Yellow No. 4 (Tartrazine), so patients who are allergic to it should exercise caution. In cases of overdose, severe hypoglycemia may occur, so immediate emergency care is needed, and appropriate treatment should be obtained at a medical institution. The safety of this medication has not been established in children, and elderly patients may require dosage adjustment due to decreased kidney function. When storing, keep this medication out of reach of children, and store in the original container to prevent misuse or degradation of quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, perceptual abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feelings of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive reactions of the skin, decreased serum sodium concentration, dysgeusia, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing of the face, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a sealed container. Moreover, the storage temperature should maintain room temperature between 1 degree and 30 degrees Celsius. This storage method will safely preserve the medication's effectiveness.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Celix Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.